These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34953778)

  • 41. Insights from the genetics of severe childhood obesity.
    Farooqi S
    Horm Res; 2007; 68 Suppl 5():5-7. PubMed ID: 18174694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats.
    Li G; Zhang Y; Wilsey JT; Scarpace PJ
    Diabetologia; 2005 Nov; 48(11):2376-85. PubMed ID: 16205885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetics of obesity.
    Clement K; Boutin P; Froguel P
    Am J Pharmacogenomics; 2002; 2(3):177-87. PubMed ID: 12383024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mendelian obesity, molecular pathways and pharmacological therapies: a review.
    Paolacci S; Borrelli A; Stuppia L; Campanile FC; Dallavilla T; Krajčovič J; Veselenyiova D; Beccari T; Unfer V; Bertelli M;
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1357-1378. PubMed ID: 30779104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic aspects of human obesity.
    Larder R; Lim CT; Coll AP
    Handb Clin Neurol; 2014; 124():93-106. PubMed ID: 25248581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Next-generation sequencing of the monogenic obesity genes LEP, LEPR, MC4R, PCSK1 and POMC in a Norwegian cohort of patients with morbid obesity and normal weight controls.
    Nordang GBN; Busk ØL; Tveten K; Hanevik HI; Fell AKM; Hjelmesæth J; Holla ØL; Hertel JK
    Mol Genet Metab; 2017 May; 121(1):51-56. PubMed ID: 28377240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypothalamic C2-domain protein involved in MC4R trafficking and control of energy balance.
    Gavini CK; Cook TM; Rademacher DJ; Mansuy-Aubert V
    Metabolism; 2020 Jan; 102():153990. PubMed ID: 31666192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical and genetic aspects of monogenic obesity].
    Lesayová D; Staník J; Gasperíková D; Klimes I
    Vnitr Lek; 2010 Oct; 56(10):1043-9. PubMed ID: 21105449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Monogenic human obesity: role of the leptin-melanocortin system in the regulation of food intake and body weight in humans].
    González-Jiménez E; Aguilar Cordero MJ; Padilla López CA; García García I
    An Sist Sanit Navar; 2012; 35(2):285-93. PubMed ID: 22948429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Updates on Rare Genetic Variants, Genetic Testing, and Gene Therapy in Individuals With Obesity.
    Zuccaro MV; LeDuc CA; Thaker VV
    Curr Obes Rep; 2024 Sep; 13(3):626-641. PubMed ID: 38822963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiating monogenic and syndromic obesities from polygenic obesity: Assessment, diagnosis, and management.
    Fitch AK; Malhotra S; Conroy R
    Obes Pillars; 2024 Sep; 11():100110. PubMed ID: 38766314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [From gene to disease; leptin and obesity].
    Pijl H; Meinders AE
    Ned Tijdschr Geneeskd; 2001 Mar; 145(12):572-4. PubMed ID: 11293996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The neuroanatomical function of leptin in the hypothalamus.
    van Swieten MM; Pandit R; Adan RA; van der Plasse G
    J Chem Neuroanat; 2014 Nov; 61-62():207-20. PubMed ID: 25007719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity.
    Irani BG; Dunn-Meynell AA; Levin BE
    Endocrinology; 2007 Jan; 148(1):310-6. PubMed ID: 17023527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The leptin melanocortin pathway and the control of body weight: lessons from human and murine genetics.
    Oswal A; Yeo GS
    Obes Rev; 2007 Jul; 8(4):293-306. PubMed ID: 17578380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Monogenic disorders of human obesity].
    Gotoda T
    Nihon Rinsho; 2009 Feb; 67(2):259-65. PubMed ID: 19202897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hypothalamic dysfunction in obesity].
    van de Sande-Lee S; Velloso LA
    Arq Bras Endocrinol Metabol; 2012 Aug; 56(6):341-50. PubMed ID: 22990637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic and Syndromic Causes of Obesity and its Management.
    Koves IH; Roth C
    Indian J Pediatr; 2018 Jun; 85(6):478-485. PubMed ID: 29177811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of the leptin-melanocortin signalling pathway in the control of food intake.
    Beckers S; Zegers D; Van Gaal LF; Van Hul W
    Crit Rev Eukaryot Gene Expr; 2009; 19(4):267-87. PubMed ID: 19817705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The human genetics of eating disorders lessons from the leptin/melanocortin system.
    Costa JL; Brennen MB; Hochgeschwender U
    Child Adolesc Psychiatr Clin N Am; 2002 Apr; 11(2):387-97. PubMed ID: 12109327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.